Excellagen is a blockbuster drug.
Over the next decade, more profitable than a covid vaccine.
Zero marketing in the last 12 months.
The energy to invest in GNBT just isn’t there today. We hope the value of Excellagen is unlocked once NGIO is allowed to run free. We hope.
today’ share price just reflects Generex fatigue.
Com’on Joe. Give us a jolt on Thursday. Put some life into this sleeping giant.
Generex Biotechnology Corp. (GNBT) Stock Research Links